Oxford Technology 2 VCT Plc – 3^rd Quarter Results

Oxford Technology 2 VCT Plc presents its quarterly update for the 3 month period commencing 1 September 2021.

The Directors have recently reviewed the valuation of its entire portfolio as at 30 November 2021.  The unaudited net asset value per ordinary share as at 30 November 2021 was 34.9p. This represents an increase of 6.8p from the net asset value per ordinary share at 31 August 2021. This increase is mainly attributable to the rise in share price of Arecor Therapeutics Plc (230p to 380p).

The total return to shareholders including previous dividends of 22.5p per share is now 57.4p per share.

The total number of ordinary shares in issue is 5,331,889.

The Directors are not aware of any other events or transactions which have taken place between 30 November 2021 and the publication of this statement which have had a material effect on the financial position of the Company.

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this information is now considered to be in the public domain.

7 January 2022

Enquiries:
Lucius Cary
Oxford Technology Management
01865 784466